Statements (21)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:drug
|
| gptkbp:activeIngredient |
gptkb:levodopa
benserazide |
| gptkbp:approvedBy |
gptkb:Europe
|
| gptkbp:ATCCode |
N04BA02
|
| gptkbp:brand |
levodopa/benserazide combination
|
| gptkbp:contraindication |
narrow-angle glaucoma
severe liver disease |
| https://www.w3.org/2000/01/rdf-schema#label |
Prolopa
|
| gptkbp:legalStatus |
prescription only
|
| gptkbp:marketedAs |
gptkb:Roche
|
| gptkbp:mechanismOfAction |
dopaminergic agent
|
| gptkbp:pregnancyCategory |
C (varies by country)
|
| gptkbp:routeOfAdministration |
oral
|
| gptkbp:sideEffect |
nausea
hypotension dyskinesia hallucinations |
| gptkbp:usedFor |
gptkb:Parkinson's_disease
|
| gptkbp:bfsParent |
gptkb:Madopar
|
| gptkbp:bfsLayer |
7
|